調査レポート | • レポートコード：QYR2104Z3733 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、転移性骨疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、放射線療法、外科的介入、腫瘍アブレーション療法）、用途別市場規模（病院、専門クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・転移性骨疾患治療の市場動向 ・企業の競争状況、市場シェア ・転移性骨疾患治療の種類別市場規模（薬物療法、放射線療法、外科的介入、腫瘍アブレーション療法） ・転移性骨疾患治療の用途別市場規模（病院、専門クリニック、外来手術センター） ・転移性骨疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性骨疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性骨疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性骨疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性骨疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck & Co.、Eli Lilly and Company、F. Hoffmann-La Roche、Amgen、Novartis、Bayer、BTG、Fresenius Kabi、Medtronic、Boston Scientific Corporation） ・結論 |
Metastatic bone disease treatments are treatment options of MBD which is a kind of cancer that begins in an organ, such as the lungs, breast, or prostate, and then spreads to bone.
Market Analysis and Insights: Global Metastatic Bone Disease Treatment Market
The global Metastatic Bone Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Bone Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Bone Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Bone Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Bone Disease Treatment market.
Global Metastatic Bone Disease Treatment Scope and Market Size
Metastatic Bone Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Bone Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck & Co.
Eli Lilly and Company
F. Hoffmann-La Roche
Amgen
Novartis
Bayer
BTG
Fresenius Kabi
Medtronic
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Bone Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Radiation Therapy
1.2.4 Surgical Intervention
1.2.5 Tumor Ablation Therapy
1.3 Market by Application
1.3.1 Global Metastatic Bone Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Bone Disease Treatment Market Perspective (2016-2027)
2.2 Metastatic Bone Disease Treatment Growth Trends by Regions
2.2.1 Metastatic Bone Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Bone Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Bone Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Bone Disease Treatment Industry Dynamic
2.3.1 Metastatic Bone Disease Treatment Market Trends
2.3.2 Metastatic Bone Disease Treatment Market Drivers
2.3.3 Metastatic Bone Disease Treatment Market Challenges
2.3.4 Metastatic Bone Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Bone Disease Treatment Players by Revenue
3.1.1 Global Top Metastatic Bone Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Bone Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Bone Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Bone Disease Treatment Revenue
3.4 Global Metastatic Bone Disease Treatment Market Concentration Ratio
3.4.1 Global Metastatic Bone Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Bone Disease Treatment Revenue in 2020
3.5 Metastatic Bone Disease Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Bone Disease Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Bone Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Bone Disease Treatment Breakdown Data by Type
4.1 Global Metastatic Bone Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Bone Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Metastatic Bone Disease Treatment Breakdown Data by Application
5.1 Global Metastatic Bone Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Bone Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Bone Disease Treatment Market Size (2016-2027)
6.2 North America Metastatic Bone Disease Treatment Market Size by Type
6.2.1 North America Metastatic Bone Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Bone Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Bone Disease Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Bone Disease Treatment Market Size by Application
6.3.1 North America Metastatic Bone Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Bone Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Bone Disease Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Bone Disease Treatment Market Size by Country
6.4.1 North America Metastatic Bone Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Bone Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Metastatic Bone Disease Treatment Market Size (2016-2027)
7.2 Europe Metastatic Bone Disease Treatment Market Size by Type
7.2.1 Europe Metastatic Bone Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Bone Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Bone Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Bone Disease Treatment Market Size by Application
7.3.1 Europe Metastatic Bone Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Bone Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Bone Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Bone Disease Treatment Market Size by Country
7.4.1 Europe Metastatic Bone Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Bone Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Bone Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Bone Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Bone Disease Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Bone Disease Treatment Market Size by Type
9.2.1 Latin America Metastatic Bone Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Bone Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Bone Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Bone Disease Treatment Market Size by Application
9.3.1 Latin America Metastatic Bone Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Bone Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Bone Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Bone Disease Treatment Market Size by Country
9.4.1 Latin America Metastatic Bone Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Bone Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Bone Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Bone Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Metastatic Bone Disease Treatment Introduction
11.1.4 Merck & Co. Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.1.5 Merck & Co. Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Metastatic Bone Disease Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Metastatic Bone Disease Treatment Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Metastatic Bone Disease Treatment Introduction
11.4.4 Amgen Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Bone Disease Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Metastatic Bone Disease Treatment Introduction
11.6.4 Bayer Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 BTG
11.7.1 BTG Company Details
11.7.2 BTG Business Overview
11.7.3 BTG Metastatic Bone Disease Treatment Introduction
11.7.4 BTG Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.7.5 BTG Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Details
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Metastatic Bone Disease Treatment Introduction
11.8.4 Fresenius Kabi Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.8.5 Fresenius Kabi Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Metastatic Bone Disease Treatment Introduction
11.9.4 Medtronic Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.9.5 Medtronic Recent Development
11.10 Boston Scientific Corporation
11.10.1 Boston Scientific Corporation Company Details
11.10.2 Boston Scientific Corporation Business Overview
11.10.3 Boston Scientific Corporation Metastatic Bone Disease Treatment Introduction
11.10.4 Boston Scientific Corporation Revenue in Metastatic Bone Disease Treatment Business (2016-2021)
11.10.5 Boston Scientific Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Metastatic Bone Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Surgical Intervention
Table 5. Key Players of Tumor Ablation Therapy
Table 6. Global Metastatic Bone Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Bone Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastatic Bone Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Metastatic Bone Disease Treatment Market Share by Regions (2016-2021)
Table 10. Global Metastatic Bone Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Metastatic Bone Disease Treatment Market Share by Regions (2022-2027)
Table 12. Metastatic Bone Disease Treatment Market Trends
Table 13. Metastatic Bone Disease Treatment Market Drivers
Table 14. Metastatic Bone Disease Treatment Market Challenges
Table 15. Metastatic Bone Disease Treatment Market Restraints
Table 16. Global Metastatic Bone Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Metastatic Bone Disease Treatment Market Share by Players (2016-2021)
Table 18. Global Top Metastatic Bone Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bone Disease Treatment as of 2020)
Table 19. Ranking of Global Top Metastatic Bone Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Metastatic Bone Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Metastatic Bone Disease Treatment Product Solution and Service
Table 23. Date of Enter into Metastatic Bone Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Metastatic Bone Disease Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Metastatic Bone Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Metastatic Bone Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Metastatic Bone Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Metastatic Bone Disease Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Metastatic Bone Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Metastatic Bone Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Metastatic Bone Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Metastatic Bone Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Metastatic Bone Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Metastatic Bone Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Metastatic Bone Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Metastatic Bone Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Metastatic Bone Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Metastatic Bone Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Metastatic Bone Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Metastatic Bone Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Metastatic Bone Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Metastatic Bone Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Metastatic Bone Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Metastatic Bone Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Metastatic Bone Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Metastatic Bone Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Metastatic Bone Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck & Co. Company Details
Table 64. Merck & Co. Business Overview
Table 65. Merck & Co. Metastatic Bone Disease Treatment Product
Table 66. Merck & Co. Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 67. Merck & Co. Recent Development
Table 68. Eli Lilly and Company Company Details
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Metastatic Bone Disease Treatment Product
Table 71. Eli Lilly and Company Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly and Company Recent Development
Table 73. F. Hoffmann-La Roche Company Details
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Metastatic Bone Disease Treatment Product
Table 76. F. Hoffmann-La Roche Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Metastatic Bone Disease Treatment Product
Table 81. Amgen Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Metastatic Bone Disease Treatment Product
Table 86. Novartis Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Metastatic Bone Disease Treatment Product
Table 91. Bayer Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. BTG Company Details
Table 94. BTG Business Overview
Table 95. BTG Metastatic Bone Disease Treatment Product
Table 96. BTG Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 97. BTG Recent Development
Table 98. Fresenius Kabi Company Details
Table 99. Fresenius Kabi Business Overview
Table 100. Fresenius Kabi Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 101. Fresenius Kabi Recent Development
Table 102. Medtronic Company Details
Table 103. Medtronic Business Overview
Table 104. Medtronic Metastatic Bone Disease Treatment Product
Table 105. Medtronic Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 106. Medtronic Recent Development
Table 107. Boston Scientific Corporation Company Details
Table 108. Boston Scientific Corporation Business Overview
Table 109. Boston Scientific Corporation Metastatic Bone Disease Treatment Product
Table 110. Boston Scientific Corporation Revenue in Metastatic Bone Disease Treatment Business (2016-2021) & (US$ Million)
Table 111. Boston Scientific Corporation Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Bone Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Radiation Therapy Features
Figure 4. Surgical Intervention Features
Figure 5. Tumor Ablation Therapy Features
Figure 6. Global Metastatic Bone Disease Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Metastatic Bone Disease Treatment Report Years Considered
Figure 11. Global Metastatic Bone Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Metastatic Bone Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Metastatic Bone Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Metastatic Bone Disease Treatment Market Share by Regions (2022-2027)
Figure 15. Global Metastatic Bone Disease Treatment Market Share by Players in 2020
Figure 16. Global Top Metastatic Bone Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bone Disease Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Metastatic Bone Disease Treatment Revenue in 2020
Figure 18. Global Metastatic Bone Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Metastatic Bone Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Metastatic Bone Disease Treatment Market Share by Type (2016-2027)
Figure 22. North America Metastatic Bone Disease Treatment Market Share by Application (2016-2027)
Figure 23. North America Metastatic Bone Disease Treatment Market Share by Country (2016-2027)
Figure 24. United States Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metastatic Bone Disease Treatment Market Share by Type (2016-2027)
Figure 28. Europe Metastatic Bone Disease Treatment Market Share by Application (2016-2027)
Figure 29. Europe Metastatic Bone Disease Treatment Market Share by Country (2016-2027)
Figure 30. Germany Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metastatic Bone Disease Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Metastatic Bone Disease Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Metastatic Bone Disease Treatment Market Share by Region (2016-2027)
Figure 40. China Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metastatic Bone Disease Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Metastatic Bone Disease Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Metastatic Bone Disease Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metastatic Bone Disease Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Metastatic Bone Disease Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Metastatic Bone Disease Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Metastatic Bone Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck & Co. Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 65. BTG Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 67. Medtronic Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 68. Boston Scientific Corporation Revenue Growth Rate in Metastatic Bone Disease Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の転移性がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 世界の消退骨病市場規模・現状・予測（2021年-2027年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界の転移性乳がん治療市場 2021：企業別、地域別、種類・用途別 The Metastatic Breast Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の骨痛治療市場規模・現状・予測（2021年-2027年） Bone pain is an ache in one or more bones in the body. The pain is generally connected to diseases that influence the normal function or structure of the bone. The major factor that drives the market is the increasing ageing population. There are various causes for bone pain disease such as Injury, …
- 世界の骨転移治療市場規模・現状・予測（2021年-2027年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…